Foghorn Therapeutics Inc.
FHTXNasdaqCIK 1822462HealthcareFiscal year ends Dec 31
Reports and events: 128 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0111:01 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-064102 |
| 2026-08-0611:03 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-053819 |
| 2026-08-0611:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-053817 |
| 2026-06-2420:01 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-045154 |
| 2026-05-0711:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-031671 |
| 2026-05-0711:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-031669 |
| 2026-04-3011:00 ET | DEF 14A | Proxy statementPeriod 2026-06-24 | 0001193125-26-193928 |
| 2026-04-2120:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-026259 |
| 2026-03-1120:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-016814 |
| 2026-03-1120:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-016805 |
| 2026-02-2312:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-010377 |
| 2026-01-1322:09 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-011881 |
| 2026-01-1213:50 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009885 |
| 2025-12-0412:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-055215 |
| 2025-11-0721:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-050683 |
| 2025-11-0512:04 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-049238 |
| 2025-11-0512:02 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-049236 |
| 2025-10-3011:27 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-047322 |
| 2025-09-0220:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001822462-25-000007 |
| 2025-08-0511:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-037606 |
| 2025-08-0511:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-037603 |
| 2025-07-0120:40 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-033784 |
| 2025-06-1720:01 ET | 8-K | 5.07 Shareholder vote results | 0001628280-25-031819 |
| 2025-05-1411:07 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-025312 |
| 2025-05-1411:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-025302 |
| 2025-05-0512:00 ET | DEF 14A | Proxy statementPeriod 2025-06-17 | 0001193125-25-112091 |
| 2025-05-0120:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-021506 |
| 2025-04-2820:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-020257 |
| 2025-03-2420:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-014475 |
| 2025-03-2020:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-014136 |
| 2025-03-0621:16 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-010933 |
| 2025-03-0621:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-010916 |
| 2025-02-0312:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-003385 |
| 2025-01-2421:00 ET | 8-K | 3.01 Delisting notice | 0001628280-25-002466 |
| 2025-01-1312:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-001226 |
| 2024-12-3012:54 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-24-052539 |
| 2024-12-1612:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-051280 |
| 2024-11-0421:14 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-045006 |
| 2024-11-0421:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-045000 |
| 2024-10-1011:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-042630 |
| 2024-08-0811:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-035867 |
| 2024-08-0811:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-035864 |
| 2024-06-2620:04 ET | 8-K | 5.07 Shareholder vote results | 0001628280-24-030137 |
| 2024-06-0320:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-026294 |
| 2024-05-2421:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-147157 |
| 2024-05-2311:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-024811 |
| 2024-05-2220:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-144934 |
| 2024-05-2012:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-024217 |
| 2024-05-0620:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-020698 |
| 2024-05-0611:03 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-020455 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.